Mangoceuticals, Inc. MGRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.31M | -3.40M | -2.77M | -7.62M | -5.42M |
| Total Depreciation and Amortization | 294.80K | 291.60K | 448.10K | 24.80K | 836.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.00K | 1.69M | 66.40K | 6.82M | 3.24M |
| Change in Net Operating Assets | 650.40K | 107.20K | 1.18M | -464.10K | 81.00K |
| Cash from Operations | -260.50K | -1.31M | -1.08M | -1.24M | -1.26M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 44.90K | -- | 75.00K | 0.00 | 600.00K |
| Total Debt Repaid | -- | -- | -206.50K | -- | -- |
| Issuance of Common Stock | 272.00K | -- | 2.22M | 1.62M | 1.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -1.05M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 316.90K | -- | 2.08M | 1.62M | 1.28M |
| Foreign Exchange rate Adjustments | -2.30K | -400.00 | -700.00 | 0.00 | 200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.10K | -1.31M | 1.01M | 380.30K | 24.50K |